STUDY OF TREATMENT IMPACT ON PATIENTS WITH ATLS, SIRS AND MOD ASSOCIATED WITH AGGRESSIVE HEMATOLOGICAL MALIGNANCIES – THE EXPERIENCE OF A ROMANIAN CENTER

EHA Library, Mihaela Andreescu, 297795

CUTANEOUS ULCERATION DURING TREATMENT WITH ALL TRANS RETINOIC ACID OF ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Olfa Kassar, 297796

SURVIVAL ANALYSIS OF CHILDHOOD ACUTE MYELOBLASTIC LEUKEMIA: DIAGNOSTIC LYMPHOPENIA AS AN UNFAVORABLE PROGNOSTIC FACTOR

EHA Library, Bambang Ardianto, 297797

ROLE OF PLASMACYTOID DENDRITIC CELL INFILTRATION IN ACUTE MYELOID LEUKEMIA

EHA Library, John Zhong, 297798

FLT3-MUTATED AML: CASE-BASED EDUCATION IMPROVES PHYSICIAN KNOWLEDGE AND SKILLS

EHA Library, Lauren Willis, 297799

INCREASED PSMD10 EXPRESSION IN BONE MARROW OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Yukie Izuka, 297800

EPIDEMIOLOGICAL DATA FOR ACUTE MYELOID LEUKEMIA IN ALBANIA FROM 2007-2018.

EHA Library, Polikron Pulluqi, 297801

OUTCOMES AND TOXICITY ASSESSMENT OF INDUCTION 7+3 (IDARUBICIN) IN COMBINATION WITH MIDOSTAURIN IN TREATMENT-NAÏVE, FLT3-MUTATED ELDERLY AML PATIENTS.

EHA Library, Ankita Tandon, 297802

HOW TO BETTER DEFINE EVENT-FREE SURVIVAL IN A CLINICAL TRIAL WITH AML PATIENTS NOT TOLERATING INTENSIVE CHEMOTHERAPY?

EHA Library, Severine Peyrard, 297803

VENETOCLAX PLUS 5AZACYTIDINE FAILURE TREATMENT IN AN IDH1 AND DNMT3A MUTATED REFRACTORY AML PATIENT WITH LEUKEMIA CUTIS

EHA Library, Jian Huang, 297804

REAL WORLD OUTCOMES OF 7+3 INDUCTION CHEMOTHERAPY FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA IN MOROCCO (A SINGLE CENTER REPORT)

EHA Library, Mahtat EL MEHDI, 297805

AZACITIDINE AS MAINTENANCE AFTER STANDARD THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA, A MEXICAN CENTER EXPERIENCE.

EHA Library, José Antonio Delapeña-Celaya, 297806

MASSIVE BONE MARROW INFILTRATION BY AGGRESSIVE NEUROENDOCRINE TUMOR MIMICKING ACUTE MYELOID LEUKEMIA

EHA Library, Rafael Rios-Tamayo, 297807

MAINTENANCE THERAPY WITH DECITABINE IN FRAIL PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA. EXPERIENCE OF A SINGLE CENTRE.

EHA Library, Alfredo Gagliardi, 297808

PHASE 1B STUDY OF CPX-351 LOWER-INTENSITY THERAPY PLUS VENETOCLAX AS FIRST-LINE TREATMENT FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY

EHA Library, Tara L. Lin, 297809

THE DIFFERENTIAL SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: A TUNISIAN SINGLE CENTRE EXPERIENCE

EHA Library, kasser olfa, 297810

CLINICAL SIGNIFICANCE OF NPM1 MUTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA IN A REAL-LIFE SETTING

EHA Library, Mirta Mikulic, 297811

DOWN REGULATION OF LEF-1 EXPRESSION IN CASES OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH ATYPICAL IMMUNOPHENOTYPE (ATYPICAL CLL)

EHA Library, Dina Sameh Soliman, 297812

EXPRESSION PATTERN AND PROGNOSTIC SIGNIFICANCE OF BCL11A GENE IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Teodora Karan-Đurašević, 297813

GENE MUTATIONS ANALYSIS AND NEW INSIGHTS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): PRELIMINARY RESULTS FROM A CLINICAL RESEARCH PROJECT BASED ON NEXT GENERATION SEQUENCING (NGS)

EHA Library, Roberta Murru, 297814

NOVEL THIENOPYRIDINE DERIVATIVES INDUCE TUBULIN DISRUPTION, CAUSE CELL CYCLE ARREST AND INHIBIT ACTIVATION OF PLCG2 IN MALIGNANT B-CELLS

EHA Library, Christopher Broughton, 297815

CIRCULATING MICROENVIRONMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: A KEY ROLE OF MONOCYTES

EHA Library, Eva Kriegová, 297816

REDOX BALANCE AS THE CRITERION FOR PERSONIFIED REGISTRATION OF RESPONSE FROM B-CLL CELLS TO THERAPY

EHA Library, Yuliya Harmaza, 297817

LEF-1 GENETIC POLYMORPHISMS IN ASSOCIATION WITH CHRONIC LYMPHOCYTIC LEUKEMIA FORMATION AND SURVIVAL

EHA Library, Enas Dawoud, 297818

GENETIC LESIONS IN RUSSIAN CLL#1 SUBSET PATIENTS.

EHA Library, Bella Biderman, 297819

LONG-TERM REAL-WORLD CLINICAL OUTCOMES FOR IBRUTINIB MONOTHERAPY TREATMENT IN RELAPSED REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA - OBSERVATIONAL STUDY OF THE POLISH ADULT LEUKEMIA STUDY GROUP (PALG)

EHA Library, Bartosz Puła, 297820

ALLELE-SPECIFIC REAL TIME PCR FOR BTK CYS481SER MUTATION DETECTION: PILOT STUDY ON RUSSIAN CLL PATIENTS TREATED WITH IBRUTINIB.

EHA Library, Ekaterina Likold, 297821

TREATMENT PRACTICES AND PATIENT BURDEN IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS IN THE REAL WORLD: AN OBSERVATIONAL, DATABASE RESEARCH IN JAPAN (CLIMBER-DBR)

EHA Library, Jun Takizawa, 297822

PROGNOSTIC FACTORS OF BACTERIAL INFECTIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)

EHA Library, Punyarat Phumphukhieo, 297823

APPLICATION OF IWCLL GUIDELINES FOR RESPONSE ASSESSMENT IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN THE REAL-WORLD: AN ANALYSIS FROM THE INFORMCLL™ REGISTRY

EHA Library, Jacqueline Barrientos, 297824

OUTCOMES OF ALLOHSCT IN CLL PATIENTS IN THE ERA OF NEW AGENTS: PAVLOV UNIVERSITY EXPERIENCE

EHA Library, Olga Kalashnikova, 297825

CLINICAL RESPONSE TO CONVENTIONAL IMMUNOSUPPRESSIVE THERAPY IN A COHORT OF 27 T-LGLL TREATED PATIENTS: EVALUATION OF BENDAMUSTINE IN RELAPSED/REFRACTORY CASES

EHA Library, Giulia Calabretto, 297826

OPTIMIZATION OF CHRONIC LYMPHOCYTIC LEUKEMIA TREATMENT USING GAME THEORY

EHA Library, Alexander Luchinin, 297827

IMPACT OF CLL SOCIETY’S (CLLS) FREE EXPERT ACCESS PROGRAM (EAP) FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS (PTS)

EHA Library, Brian Koffman, 297828

AN INTERNATIONAL DELPHI CONSENSUS BUILDING APPROACH TO PATIENT ASSESSMENT AND USE OF IMMUNOGLOBULIN TREATMENT FOR SECONDARY IMMUNE DEFICIENCIES IN HEMATOLOGICAL MALIGNANCY

EHA Library, Michael Albert, 297829

MULTICENTER, RETROSPECTIVE ANALYSIS OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN KOREA

EHA Library, Jun Ho Yi, 297831

DIAGNOSTIC ROLE OF PET/CT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA AND RICHTER'S TRANSFORMATION

EHA Library, Huayuan Zhu, 297832

THE PROGNOSTIC SIGNIFICANCE OF DIFFERENT TYPES OF NEUTROPENIA IN CLL PATIENTS TREATED WITH FCR

EHA Library, Kristina Tomic, 297833

SECONDARY HYPOGAMMAGLOBULINEMIA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING IBRUTINIB THERAPY

EHA Library, Serhat Çelik, 297834

FIRST REPORT OF UNIQUE EXPRESSION OF RECEPTOR FOR ALFA FETO-PROTEIN (RECAF) IN ADULT B-NHL/ CLL PATIENTS

EHA Library, Walaa Elsalakawy, 297835

CLINICO-BIOLOGICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN ASSOCIATION WITH ANOTHER B-CELL LYMPHOPROLIFERATIVE DISORDER.

EHA Library, Arthur Bobin, 297836

IBRUTINIB VERSUS BENDAMUSTINE PLUS RITUXIMAB IN UNTREATED CLL. RISK FACTORS AND COMPARISON WITH THE ALLIANCE TRIAL

EHA Library, Adolfo De La Fuente, 297837

IMPACT OF AUTOIMMUNE CYTOPENIA ON THE SURVIVAL GLOBAL (OS) OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): MULTIVARIATE REGRESSION ANALYSIS OF 147 CASES

EHA Library, ABBADI Mohamed Rafik, 297838

WNT3 AND LEF1 EXPRESSION LEVELS AND OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS.

EHA Library, manal aboelmagd, 297839

LONG-TERM EFFICACY AND SAFETY OF IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA IN ROUTINE CLINICAL PRACTICE IN RUSSIA

EHA Library, Iuliia Rogovaia, 297840

EFFICACY, SAFETY AND HEALTH RELATED QUALITY OF LIFE (HR QOL) OF GENERIC AND INNOVATOR IBRUTINIB IN INDIAN CLL PATIENTS

EHA Library, Charanpreet Singh, 297841

PHASE 3 TRIAL OF ACALABRUTINIB IN COMBINATION WITH VENETOCLAX, WITH AND WITHOUT OBINUTUZUMAB VERSUS CHEMOIMMUNOTHERAPY FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Jennifer R. Brown, 297842

IGHV MUTATIONAL ANALYSIS IN CLL- RELEVANCE OF USING FR1 PRIMERS IN THE DETERMINATION OF MUTATION STATUS

EHA Library, Gee Fung How, 297843

CARDIO-HEMATOLOGY RECOMMENDATIONS FOR IBRUTINIB CARDIOVASCULAR SIDE EFFECTS MANAGEMENT

EHA Library, Teresa Lopez-Fernandez, 297844

FEATURES OF THE CLINIC AND MOLECULAR GENETIC MANIFESTATIONS OF THE “SMOLDERING” FORM OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Olga Smirnova, 297845

PREVALENCE OF GENETIC ABNORMALITY IN CHRONIC LYMPHOCYTIC LEUKEMIA BY FLUORESCENCE IN SITU HYBRIDIZATION AND ITS CO-RELATION WITH OUTCOME, A STUDY FROM A RESOURCE LIMITED SETTING IN SOUTHERN INDIA.

EHA Library, Aditi Shah, 297846

DIAGNOSTIC ALGORITHM FOR THE “SMOLDERING” FORM OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Olga Smirnova, 297847

THE EXPERIENCE OF TIMISOARA HEMATOLOGY CLINIC IN THE TREATMENT OF AUTOIMMUNE HEMOLYTIC ANEMIA OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMYA

EHA Library, Oana Silvana Sarau, 297848

DECISION TO STOP TYROSINE KINASE INHIBITORS (TKIS) WITH BONE MARROW LEUKEMIC STEM CELL LEVEL: DETECTION OF BCR-ABL IN PERIPHERAL BLOOD MAY NOT BE ENOUGH

EHA Library, Zehra Narli Ozdemir, 297849

GLOBAL GENE EXPRESSION AND SPECIFIC MRNA-MIRNA INTERACTIONS IN PATIENTS WITH CML PRIOR TO AND 3, 6, AND 12-MONTHS AFTER INTRODUCTION OF TKI THERAPY

EHA Library, Zofia Ulańczyk, 297850

MODELLING CHRONIC MYELOID LEUKEMIA IN ZEBRAFISH

EHA Library, Simona Bernardi, 297851

CLINICAL SIGNIFICANCE OF LARGE E3 UBIQUITIN LIGASE HERC1 IN CHRONIC MYELOGENOUS LEUKEMIA.

EHA Library, Muhammad Shahzad Ali, 297852

NOVEL BCR-ABL1 KINASE DOMAIN MUTATIONS IN RUSSIAN PATIENTS RESISTANT TO ALL GENERATIONS OF TYROSINE KINASE INHIBITORS

EHA Library, Adhamjon Abdullaev, 297853

EXPRESSION OF LEVEL MIR-17-92 GENES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN DIFFERENT PHASES OF DISEASE

EHA Library, Anna Lyamkina, 297854

DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS: A TUNISIAN EXPERIENCE.

EHA Library, Rim Frikha, 297855

TARGETING AUTOPHAGY OVERCOMES IMATINIB RESISTANCE THROUGH THE INHIBITION OF HISTONE DEACETYLASES IN CHRONIC MYELOD LEUMEIC CELLS

EHA Library, Eun Sun Yoo, 297856

IMPACT OF THE MAJOR BCR-ABL1 TRANSCRIPT TYPE ON CLINICAL AND BIOLOGICAL PARAMETERS IN WESTERN ALGERIAN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Mourad Nachi, 297857

IN VITRO INVESTIGATION OF THE IMPACT OF BCR-ABL TYROSINE KINASE INHIBITORS ON ENDOTHELIAL CELLS

EHA Library, Hélène Haguet, 297858

MOLECULAR RESPONSE RATE AND SAFETY IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WHO SWITCHED TO GENERIC IMATINIB: LONG-TERM ANALYSIS

EHA Library, Emilia Scalzulli, 297859

HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO DISCONTINUED TREATMENT

EHA Library, Adi Abulafia, 297860

DISCONTINUATION OF TYROSINE KINASE INHIBITOR (TKI) THERAPY IN CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) IN US CLINICAL PRACTICE AFTER GUIDELINE UPDATES

EHA Library, Xiting Cao, 297861

THE PREVALENCE OF SECONDARY MALIGNANCIES AMONG 234 PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH TYROSINE KINASE INHIBITORS- SINGLE CENTER REPORT

EHA Library, Elżbieta Szczepanek, 297862

CHRONIC MYELOID LEUKEMIA IN ADOLESCENTS AND YOUNG ADULTS: DIFFERENCES WITH OTHER AGE GROUPS IN A MULTICENTRIC COHORT FROM ARGENTINA.

EHA Library, María Pagani, 297863

FIVE YEARS OF EXPERIENCE OF BCR-ABL TESTING IN THE EVALUATION OF NON-LYMPHOCYTIC LEUKOCYTOSIS

EHA Library, Caleb Smith, 297864

EVALUATION OF LABORATORY AND INSTRUMENTAL INDICATORS OF HEART FAILURE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDERGOING TREATMENT WITH TYROSINE KINASE INHIBITORS

EHA Library, Elza Lomaia, 297865

ANALYSIS OF TKI DISCONTINUATION IN CML PATIENTS AS PART OF DAILY CLINICAL PRACTICE IN HOSPITALS OF THE CANARY ISLANDS, SPAIN

EHA Library, Adrián Segura Díaz, 297866

DOSE REDUCTION OF SECOND GENERATION TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH MAJOR AND DEEP MOLECULAR RESPONSE

EHA Library, Margarita Gurianova, 297867

ENDOCRINE EFFECTS INDUCED BY TYROSINE KINASE INHIBITORS DURING THE TREATMENT OF CHRONIC MYELOID LEUKEMIA

EHA Library, Soraya Bougherira, 297868

CHARACTERISTICS OF CML PATIENTS WITH PRIMARY AND SECONDARY FAILURE TO STANDARD DOSE OF IMATINIB IN THE FIRST LINE AND THEIR RESPONSE TO SECOND ТРЕАТМЕНТ LINE

EHA Library, Danijela Lekovic, 297869

GENERIC IMATINIB TREATMENT IN CML. ALGERIAN STUDY OVER 12 YEARS (2007 - 2018): ABOUT 881 CASES, GAT-LMC

EHA Library, DJOUADI LAHLOU KHEDIDJA, 297870

THE EVOLUTION OF THE TREATMENT OF CHRONIC MYELOID LEUKEMIA: A NATIONWIDE POPULATION-BASED STUDY IN TAIWAN

EHA Library, Chia-Jen Liu, 297871

PRELIMINARY RESULTS OF THE FIRST TKI DISCONTINUATION STUDY IN PATIENTS WITH CML WHO ACHIEVED DEEP AND SUSTAINED MOLECULAR REMISSION IN ARGENTINA (ARGENTINA STOP TRIAL – AST)

EHA Library, Ana Varela, 297872

SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA : A SINGLE CENTER EXPERIENCE

EHA Library, Maria Pina Simula, 297873

IMPACT OF INEQUITIES IN ACCESS IN THE RESPONSES TO TYROSINE KINASE INHIBITORS IN COLOMBIAN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: FIRST RENEHOC REPORT ON CML

EHA Library, Virginia Abello, 297874

LONG-TERM OUTCOMES OF TYROSINE KINASE INHIBITOR TREATMENT FOR CHRONIC MYELOID LEUKEMIA : A REAL WORLD DATA FROM MALAYSIA

EHA Library, Ahmad Zakiyy Mohamed, 297875

THE IMPORTANCE OF MOLECULAR MONITORING CHRONIC MYELOID LEUKEMIA ( CML) PATIENTS ON MONTHS 3 AND 12 IN LOW INCOME-COUNTRIES LIKE ALBANIA

EHA Library, Alma Cili, 297876

DEMOGRAPHIC/CLINICAL FEATURES AND TREATMENT OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS IN TURKEY: REAL-WORLD DATA

EHA Library, Guray Saydam, 297877

AN INVESTIGATION SURVEY IN CENTRAL CHINA: TKI DE-ESCALATION TREAMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Weiming Li, 297878

BCR-ABL1 TRANSCRIPTS E13A2 AND E14A2 IN RELATION TO SURVIVAL AND MOLECULAR RESPONSES IN CML PATIENTS IN BOSNIA

EHA Library, Amina Kurtovic-Kozaric, 297879

CHRONIC MYELOID LEUKEMIA: ABOUT 114 CASES

EHA Library, hajar khibri, 297880

RARE BCR-ABL TRANSCRIPTS IN CML: E6A2 WITH EXTRAMEDULLARY LESIONS AND UNUSUAL E2A2 WITH PATIAL DELETION AND STIMULTANEOUS INSERTION (CASE REPORTS)

EHA Library, Andrey Misyurin, 297881

EVALUATION OF THE SELECTIVITY OF BCR-ABL TYROSINE KINASE INHIBITORS (TKIS): A SYSTEMATIC REVIEW

EHA Library, Hélène Haguet, 297882

REAL WORLD DATA OF TREATMENT FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) TREATED AT TERTIARY CARE ONCOLOGY CENTRE FROM INDIA

EHA Library, Lakhan Kashyap, 297883

A CASE OF PRELEUKEMIC CHRONIC MYELOID LEUKEMIA FOLLOWING CHEMOTHERAPY AND AUTOLOGOUS TRANSPLANTATION FOR T-LYMPHOBLASTIC LYMPHOMA

EHA Library, Hyunji Choi, 297884

#10YEARCHALLENGE CHRONIC MYELOID LEUKEMIA: SINGLE CENTER REAL-LIFE EXPERIENCE ON CML MANAGEMENT. OUTCOMES OF EVOLVING TREATMENT STRATEGIES.

EHA Library, gianni binotto, 297885

THERAPEUTIC RESULTS OF SECOND GENERATION TKI IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA

EHA Library, Olfa Kassar, 297886

PONS – A PHASE 2 STUDY WITH PONATINIB AS A 2ND LINE THERAPY FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE WHO ARE RESISTANT OR INTOLERANT TO PRIOR 1ST LINE TKI

EHA Library, Philipp Le Coutre, 297887

PREVALENCE OF IMATINIB RESISTANCE IN CHRONIC MYELOID LEUKEMIA (CML): EXPERIENCE FROM A TERTIARY CARE CANCER CENTRE IN EASTERN INDIA

EHA Library, Debmalya Bhattacharyya, 297888

SINGULARITIES OF MYELODYSPLASTIC SYNDROMES WITH HIGH RISK OF LEUKEMIC TRANSFORMATION

EHA Library, Laura Sánchez Vega, 297889

FGF-23 LINKS IMPAIRED ERYTHROPOIESIS AND BONE METABOLISM IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Heike Weidner, 297890

IMMUNE SYSTEM DYSFUNCTION CHARACTERIZATION IN LOWER RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Antonieta Molero Yordi, 297891

MICRORNA 99B AND LET7A AS DIAGNOSTIC PARAMETERS IN MYELODYSPLASTIC SYNDROME

EHA Library, Inga MANDAC ROGULJ, 297892

SEQUENCE VARIANTS OF PPM1D IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES WITH AND WITHOUT COMPLEX ABERRATIONS

EHA Library, Lea Naomi Eder, 297893

RIGOSERTIB AND AZACITIDINE HAS EFFECTS ON INNATE IMMUNE SIGNALING IN AN IN VITRO MODEL OF THE MYELODYSPLASTIC SYNDROME

EHA Library, Lewis Silverman, 297894

FEATURES OF FUNCTIONING OF HEMATOPOIETIC BONE MARROW PROGENITOR CELLS IN MDS, WHICH IS TRANSFORMED INTO ACUTE MYELOBLASTIC LEUKEMIA

EHA Library, Nadiia Bilko, 297895